The Prognostic Value of Elevated Perioperative Neutrophil-Lymphocyte Ratio in Predicting Postoperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-Analysis.


Journal

Heart, lung & circulation
ISSN: 1444-2892
Titre abrégé: Heart Lung Circ
Pays: Australia
ID NLM: 100963739

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 16 09 2019
revised: 20 11 2019
accepted: 28 11 2019
pubmed: 25 2 2020
medline: 17 3 2021
entrez: 25 2 2020
Statut: ppublish

Résumé

The neutrophil-lymphocyte ratio (NLR) is an emerging inflammatory perioperative biomarker which has been studied to predict the incidence of postoperative atrial fibrillation (POAF) after cardiac surgery. This systematic review and meta-analysis aimed to evaluate the prognostic accuracy of elevated perioperative NLR in predicting POAF after cardiac surgery. Multiple databases were searched from inception to May 2019 for prognostic studies on perioperative NLR and POAF following cardiac surgery. Maximally adjusted odds ratios (OR) with associated confidence intervals were obtained from each included study and pooled using random effects inverse variance modelling for preoperative NLR measurements, while standardised mean differences were pooled for postoperative NLR values. The significance of inter- and intra-study heterogeneity was explored using meta-regression. 1,799 unique studies satisfied selection criteria, from which 12 studies incorporating 9,262 participants were included. Elevated preoperative NLR significantly predicted POAF, with a pooled OR of 1.42 (95% CI 1.16-1.72). Multiple predefined covariates contributed to inter-study heterogeneity; however, only prevalence of hypertension (p=0.0055), history of congestive cardiac failure (p=0.0282) and average ejection fraction (p=0.0359) were significant effect modifiers. Elevated postoperative NLR was not a significant predictor of POAF (standardised mean difference 1.60 [95% CI -0.56-3.77] between POAF+ and POAF- groups). Elevated preoperative NLR is a promising prognostic biomarker for POAF, but residual sources of heterogeneity remain. Larger scale validation studies are required to justify the integration of preoperative NLR testing into routine clinical practice.

Sections du résumé

BACKGROUND BACKGROUND
The neutrophil-lymphocyte ratio (NLR) is an emerging inflammatory perioperative biomarker which has been studied to predict the incidence of postoperative atrial fibrillation (POAF) after cardiac surgery. This systematic review and meta-analysis aimed to evaluate the prognostic accuracy of elevated perioperative NLR in predicting POAF after cardiac surgery.
METHODS METHODS
Multiple databases were searched from inception to May 2019 for prognostic studies on perioperative NLR and POAF following cardiac surgery. Maximally adjusted odds ratios (OR) with associated confidence intervals were obtained from each included study and pooled using random effects inverse variance modelling for preoperative NLR measurements, while standardised mean differences were pooled for postoperative NLR values. The significance of inter- and intra-study heterogeneity was explored using meta-regression.
RESULTS RESULTS
1,799 unique studies satisfied selection criteria, from which 12 studies incorporating 9,262 participants were included. Elevated preoperative NLR significantly predicted POAF, with a pooled OR of 1.42 (95% CI 1.16-1.72). Multiple predefined covariates contributed to inter-study heterogeneity; however, only prevalence of hypertension (p=0.0055), history of congestive cardiac failure (p=0.0282) and average ejection fraction (p=0.0359) were significant effect modifiers. Elevated postoperative NLR was not a significant predictor of POAF (standardised mean difference 1.60 [95% CI -0.56-3.77] between POAF+ and POAF- groups).
CONCLUSIONS CONCLUSIONS
Elevated preoperative NLR is a promising prognostic biomarker for POAF, but residual sources of heterogeneity remain. Larger scale validation studies are required to justify the integration of preoperative NLR testing into routine clinical practice.

Identifiants

pubmed: 32089488
pii: S1443-9506(19)31549-5
doi: 10.1016/j.hlc.2019.11.021
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1015-1024

Informations de copyright

Copyright © 2019 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Auteurs

Zhengyang Liu (Z)

Department of Anaesthesia, Royal Melbourne Hospital, Melbourne, Vic, Australia; Melbourne Medical School, University of Melbourne, Melbourne, Vic, Australia.

Jacqueline Nguyen Khuong (J)

Department of Anaesthesia, Royal Melbourne Hospital, Melbourne, Vic, Australia; Melbourne Medical School, University of Melbourne, Melbourne, Vic, Australia.

Carla Borg Caruana (C)

Department of Anaesthesia, Royal Melbourne Hospital, Melbourne, Vic, Australia.

Sarah M Jackson (SM)

Department of Anaesthesia, Royal Melbourne Hospital, Melbourne, Vic, Australia; Melbourne Medical School, University of Melbourne, Melbourne, Vic, Australia.

Ryan Campbell (R)

Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

Dhruvesh M Ramson (DM)

Department of Surgery, Monash University, Melbourne, Vic, Australia.

Jahan C Penny-Dimri (JC)

Department of Surgery, Monash University, Melbourne, Vic, Australia.

Michael Kluger (M)

Department of Anaesthesia, Royal Melbourne Hospital, Melbourne, Vic, Australia.

Reny Segal (R)

Department of Anaesthesia, Royal Melbourne Hospital, Melbourne, Vic, Australia.

Luke A Perry (LA)

Department of Anaesthesia, Royal Melbourne Hospital, Melbourne, Vic, Australia. Electronic address: Luke.Perry@mh.org.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH